Multi-centre trial of naproxen and phenylbutazone in acute gout.
Naproxen 750 mg as a single dose followed by 250 mg three times daily has been compared with phenylbutazone 200 mg four times daily for 48 hours followed by 200 mg three times daily for the treatment of acute gout in an open study on 41 patients. The drugs were equally effective with few and relatively mild side effects. Naproxen is a useful alternative agent for the treatment of acute gout.
D000328:Adult; D000367:Age Factors; D000368:Aged; D001826:Body Fluids / Q000378:metabolism; D004487:Edema / Q000139:chemically induced; D005260:Female; D006073:Gout / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009280:Naphthaleneacetic Acids / Q000627:therapeutic use*; D009288:Naproxen / Q000009:adverse effects / Q000627:therapeutic use*; D010653:Phenylbutazone / Q000627:therapeutic use*
D009280:Naphthaleneacetic Acids; D009288:Naproxen; D010653:Phenylbutazone